OpenURL Connection Search

Select item for more details and to access through your institution.

Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas.
Published in:
Laryngoscope Investigative Otolaryngology, 2021, v. 6, n. 5, p. 1008, doi. 10.1002/lio2.643
By:
- Welling, D. Bradley;
- Collier, Katharine A.;
- Burns, Sarah S.;
- Oblinger, Janet L.;
- Shu, Edina;
- Miles‐Markley, Beth A.;
- Hofmeister, Craig C.;
- Makary, Mina S.;
- Slone, H. Wayne;
- Blakeley, Jaishri O.;
- Mansouri, S. Alireza;
- Neff, Brian A.;
- Jackler, Robert K.;
- Mortazavi, Amir;
- Chang, Long‐Sheng
Publication type:
Article
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01120-9
By:
- Joseph, Nisha S.;
- Kaufman, Jonathan L.;
- Gupta, Vilas A.;
- Hofmeister, Craig C.;
- Dhodapkar, Madhav V.;
- Boise, Lawrence H.;
- DiCamillo, Sara M.;
- Roberts, Danielle;
- Nooka, Ajay K.;
- Lonial, Sagar
Publication type:
Article
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00963-y
By:
- Scott, Sara A.;
- Marin, Ellen M.;
- Maples, Kathryn T.;
- Joseph, Nisha S.;
- Hofmeister, Craig C.;
- Gupta, Vikas A.;
- Dhodapkar, Madhav V.;
- Kaufman, Jonathan L.;
- Lonial, Sagar;
- Nooka, Ajay K.
Publication type:
Article
Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma.
Published in:
British Journal of Haematology, 2018, v. 182, n. 2, p. 231, doi. 10.1111/bjh.15394
By:
- Richardson, Paul G.;
- Hofmeister, Craig C.;
- Rosenbaum, Cara A.;
- Htut, Myo;
- Vesole, David H.;
- Berdeja, Jesus G.;
- Liedtke, Michaela;
- Chari, Ajai;
- Smith, Stephen D.;
- Lebovic, Daniel;
- Raje, Noopur;
- Byrne, Catriona;
- Liao, Eileen;
- Gupta, Neeraj;
- Bacco, Alessandra Di;
- Estevam, Jose;
- Berg, Deborah;
- Baz, Rachid
Publication type:
Article
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma.
Published in:
British Journal of Haematology, 2015, v. 171, n. 1, p. 74, doi. 10.1111/bjh.13527
By:
- Sborov, Douglas W.;
- Benson, Don M.;
- Williams, Nita;
- Huang, Ying;
- Bowers, Mindy A.;
- Humphries, Kristina;
- Efebera, Yvonne;
- Devine, Steven;
- Hofmeister, Craig C.
Publication type:
Article
The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo.
Published in:
PLoS ONE, 2010, v. 5, n. 6, p. 1, doi. 10.1371/journal.pone.0010941
By:
- Lucas, David M.;
- Alinari, Lapo;
- West, Derek A.;
- Davis, Melanie E.;
- Edwards, Ryan B.;
- Johnson, Amy J.;
- Blum, Kristie A.;
- Hofmeister, Craig C.;
- Freitas, Michael A.;
- Parthun, Mark R.;
- Dasheng Wang;
- Lehman, Amy;
- Xiaoli Zhang;
- Jarjoura, David;
- Samuel K.Kulp;
- Croce, Carlo M.;
- Grever, Michael R.;
- Ching-Shih Chen;
- Baiocchi, Robert A.;
- Byrd, John C.
Publication type:
Article
Characterization of multiple myeloma vesicles by label-free relative quantitation.
Published in:
Proteomics, 2013, v. 13, n. 20, p. 3013, doi. 10.1002/pmic.201300142
By:
- Harshman, Sean W.;
- Canella, Alessandro;
- Ciarlariello, Paul D.;
- Rocci, Alberto;
- Agarwal, Kitty;
- Smith, Emily M.;
- Talabere, Tiffany;
- Efebera, Yvonne A.;
- Hofmeister, Craig C.;
- Benson, Don M.;
- Paulaitis, Michael E.;
- Freitas, Michael A.;
- Pichiorri, Flavia
Publication type:
Article
Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC.
Published in:
Cancer Immunology, Immunotherapy, 2013, v. 62, n. 12, p. 1841, doi. 10.1007/s00262-013-1493-8
By:
- Collins, Shauna M.;
- Bakan, Courtney E.;
- Swartzel, Gina D.;
- Hofmeister, Craig C.;
- Efebera, Yvonne A.;
- Kwon, Hakju;
- Starling, Gary C.;
- Ciarlariello, David;
- Bhaskar, Shakthi;
- Briercheck, Edward L.;
- Hughes, Tiffany;
- Yu, Jianhua;
- Rice, Audie;
- Benson Jr., Don M.
Publication type:
Article
Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant.
Published in:
British Journal of Clinical Pharmacology, 2020, v. 86, n. 11, p. 2165, doi. 10.1111/bcp.14308
By:
- Sweiss, Karen;
- Vemu, Bhaskar;
- Hofmeister, Craig C.;
- Wenzler, Eric;
- Calip, Gregory Sampang;
- Galvin, John P.;
- Mahmud, Nadim;
- Rondelli, Damiano;
- Johnson, Jeremy James;
- Patel, Pritesh
Publication type:
Article
Population pharmacokinetics of lenalidomide in patients with B‐cell malignancies.
Published in:
British Journal of Clinical Pharmacology, 2019, v. 85, n. 5, p. 924, doi. 10.1111/bcp.13873
By:
- Hughes, Jim H.;
- Phelps, Mitch A.;
- Upton, Richard N.;
- Reuter, Stephanie E.;
- Gao, Yue;
- Byrd, John C.;
- Grever, Michael R.;
- Hofmeister, Craig C.;
- Marcucci, Guido;
- Blum, William;
- Blum, Kristie A.;
- Foster, David J.R.
Publication type:
Article
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.
Published in:
Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09555-6
By:
- Barwick, Benjamin G.;
- Neri, Paola;
- Bahlis, Nizar J.;
- Nooka, Ajay K.;
- Dhodapkar, Madhav V.;
- Jaye, David L.;
- Hofmeister, Craig C.;
- Kaufman, Jonathan L.;
- Gupta, Vikas A.;
- Auclair, Daniel;
- Keats, Jonathan J.;
- Lonial, Sagar;
- Vertino, Paula M.;
- Boise, Lawrence H.
Publication type:
Article
Initial genome sequencing and analysis of multiple myeloma.
Published in:
Nature, 2011, v. 471, n. 7339, p. 467, doi. 10.1038/nature09837
By:
- Chapman, Michael A.;
- Lawrence, Michael S.;
- Keats, Jonathan J.;
- Cibulskis, Kristian;
- Sougnez, Carrie;
- Schinzel, Anna C.;
- Harview, Christina L.;
- Brunet, Jean-Philippe;
- Ahmann, Gregory J.;
- Adli, Mazhar;
- Anderson, Kenneth C.;
- Ardlie, Kristin G.;
- Auclair, Daniel;
- Baker, Angela;
- Bergsagel, P. Leif;
- Bernstein, Bradley E.;
- Drier, Yotam;
- Fonseca, Rafael;
- Gabriel, Stacey B.;
- Hofmeister, Craig C.
Publication type:
Article
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity.
Published in:
NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00999-6
By:
- Moreno, Alberto;
- Manning, Kelly;
- Azeem, Maryam I.;
- Nooka, Ajay K.;
- Ellis, Madison;
- Manalo, Renee Julia;
- Switchenko, Jeffrey M.;
- Wali, Bushra;
- Kaufman, Jonathan L.;
- Hofmeister, Craig C.;
- Joseph, Nisha S.;
- Lonial, Sagar;
- Dhodapkar, Kavita M.;
- Dhodapkar, Madhav V.;
- Suthar, Mehul S.
Publication type:
Article
Chemotherapeutic Agents Increase the Risk for Pulmonary Function Test Abnormalities in Patients With Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 5, p. 325, doi. 10.1016/j.clml.2012.06.002
By:
- Bruce, Jarrod T.;
- Tran, Jerry M.;
- Phillips, Gary;
- Elder, Pat;
- Mastronarde, John G.;
- Devine, Steven M.;
- Hofmeister, Craig C.;
- Wood, Karen L.
Publication type:
Article
Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies.
Published in:
European Journal of Haematology, 2019, v. 102, n. 6, p. 494, doi. 10.1111/ejh.13231
By:
- Dimopoulos, Meletios A.;
- Laubach, Jacob P.;
- Richardson, Paul G.;
- Echeveste Gutierrez, Maria Asunción;
- Grzasko, Norbert;
- Hofmeister, Craig C.;
- San‐Miguel, Jesus F.;
- Kumar, Shaji;
- Labotka, Richard;
- Lu, Vickie;
- Berg, Deborah;
- Byrne, Catriona;
- Teng, Zhaoyang;
- Liu, Guohui;
- Velde, Helgi
Publication type:
Article
Evaluating the Impacts of CYP3A4*1B and CYP3A5*3 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant.
Published in:
Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 1, p. 9, doi. 10.21873/cgp.20360
By:
- LIJUNAN;
- CHOYU KYOUNG;
- SBOROV, DOUGLAS W.;
- PHELPS, MITCH A.;
- HOFMEISTER, CRAIG C.;
- POI, MING J.
Publication type:
Article
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 599, doi. 10.1007/s00280-020-04229-3
By:
- Collier, Katharine A.;
- Valencia, Hugo;
- Newton, Herbert;
- Hade, Erinn M.;
- Sborov, Douglas W.;
- Cavaliere, Robert;
- Poi, Ming;
- Phelps, Mitch A.;
- Liva, Sophia G.;
- Coss, Christopher C.;
- Wang, Jiang;
- Khountham, Soun;
- Monk, Paul;
- Shapiro, Charles L.;
- Piekarz, Richard;
- Hofmeister, Craig C.;
- Welling, D. Bradley;
- Mortazavi, Amir
Publication type:
Article
Pharmacokinetic‐Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High‐Dose Melphalan for Autologous Stem Cell Transplant.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2018, v. 7, n. 11, p. 748, doi. 10.1002/psp4.12345
By:
- Cho, Yu Kyoung;
- Irby, Donald J.;
- Li, Junan;
- Sborov, Douglas W.;
- Mould, Diane R.;
- Badawi, Mohamed;
- Dauki, Anees;
- Lamprecht, Misty;
- Rosko, Ashley E.;
- Fernandez, Soledad;
- Hade, Erinn M.;
- Hofmeister, Craig C.;
- Poi, Ming;
- Phelps, Mitch A.
Publication type:
Article
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00801-1
By:
- Maples, Kathryn T.;
- Hall, Kevin H.;
- Joseph, Nisha S.;
- Hofmeister, Craig C.;
- Gupta, Vikas;
- Dhodapkar, Madhav V.;
- Kaufman, Jonathan L.;
- Nooka, Ajay K.;
- Lonial, Sagar
Publication type:
Article
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.
Published in:
2023
By:
- Maples, Kathryn T.;
- Hall, Kevin H.;
- Joseph, Nisha S.;
- Hofmeister, Craig C.;
- Gupta, Vikas;
- Dhodapkar, Madhav V.;
- Kaufman, Jonathan L.;
- Nooka, Ajay K.;
- Lonial, Sagar
Publication type:
Letter
Venetoclax ex vivo functional profiling predicts improved progression-free survival.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00710-9
By:
- Gupta, Vikas A.;
- Matulis, Shannon M.;
- Barwick, Benjamin G.;
- Bog, R. Devin;
- Shebelut, Conrad W.;
- Shanmugam, Mala;
- Neri, Paola;
- Bahlis, Nizar J.;
- Dhodapkar, Madhav V.;
- Heffner, Leonard T.;
- Hofmeister, Craig C.;
- Joseph, Nisha S.;
- Lonial, Sagar;
- Kaufman, Jonathan L.;
- Jaye, David L.;
- Nooka, Ajay K.;
- Boise, Lawrence H.
Publication type:
Article
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma.
Published in:
Blood Cancer Journal, 2020, v. 10, n. 12, p. 1, doi. 10.1038/s41408-020-00393-0
By:
- Gu, Yanyan;
- Barwick, Benjamin G.;
- Shanmugam, Mala;
- Hofmeister, Craig C.;
- Kaufman, Jonathan;
- Nooka, Ajay;
- Gupta, Vikas;
- Dhodapkar, Madhav;
- Boise, Lawrence H.;
- Lonial, Sagar
Publication type:
Article
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone.
Published in:
Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0254-0
By:
- Schmidt, Timothy M.;
- Barwick, Benjamin G.;
- Joseph, Nisha;
- Heffner, Leonard T.;
- Hofmeister, Craig C.;
- Bernal, Leon;
- Dhodapkar, Madhav V.;
- Gupta, Vikas A.;
- Jaye, David L.;
- Wu, Jiayi;
- Goyal, Subir;
- Chen, Zhengjia;
- Boise, Lawrence H.;
- Lonial, Sagar;
- Nooka, Ajay K.;
- Kaufman, Jonathan L.
Publication type:
Article
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.
Published in:
Pharmacotherapy, 2022, v. 42, n. 3, p. 233, doi. 10.1002/phar.2667
By:
- Sivakumar, Akhilesh;
- Bryson, Evan B.;
- Hall, Kevin H.;
- Maples, Kathryn T.;
- Goyal, Subir;
- Joseph, Nisha S.;
- Hofmeister, Craig C.;
- Kaufman, Jonathan L.;
- Lonial, Sagar;
- Nooka, Ajay K.;
- Harvey, Robert Donald
Publication type:
Article
XRCC1‐mediated DNA repair is associated with progression‐free survival of multiple myeloma patients after autologous stem cell transplant.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 12, p. 2327, doi. 10.1002/mc.23121
By:
- Persaud, Avinash K.;
- Li, Junan;
- Johnson, Jasmine A.;
- Seligson, Nathan;
- Sborov, Douglas W.;
- Duah, Ernest;
- Cho, Yu Kyoung;
- Wang, Danxin;
- Phelps, Mitch A.;
- Hofmeister, Craig C.;
- Poi, Ming J.
Publication type:
Article
Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant.
Published in:
Molecular Carcinogenesis, 2017, v. 56, n. 7, p. 1722, doi. 10.1002/mc.22626
By:
- Poi, Ming J.;
- Li, Junan;
- Sborov, Douglas W.;
- VanGundy, Zachary;
- Cho, Yu Kyoung;
- Lamprecht, Misty;
- Pichiorri, Flavia;
- Phelps, Mitch A.;
- Hofmeister, Craig C.
Publication type:
Article
Serum free light chains in myeloma patients with an intact M protein by immunofixation: potential roles for response assessment and prognosis during induction therapy with novel agents.
Published in:
Hematological Oncology, 2012, v. 30, n. 3, p. 156, doi. 10.1002/hon.1019
By:
- Mori, Sherry;
- Crawford, Brooke S;
- Roddy, Julianna VF;
- Phillips, Gary;
- Elder, Pat;
- Hofmeister, Craig C;
- Efebera, Yvonne;
- Benson, Don M
Publication type:
Article
TTP disease course is independent of myeloma treatment and response.
Published in:
American Journal of Hematology, 2010, v. 85, n. 4, p. 304, doi. 10.1002/ajh.21646
By:
- Hofmeister, Craig C.;
- Jin, Ming;
- Cataland, Spero R.;
- Benson, Don M.;
- Wu, Haifeng M.
Publication type:
Article
CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2023.1334440
By:
- Seligson, Nathan D.;
- Xunjie Zhang;
- Zemanek, Mark C.;
- Johnson, Jasmine A.;
- VanGundy, Zachary;
- Danxin Wang;
- Phelps, Mitch A.;
- Roddy, Julianna;
- Hofmeister, Craig C.;
- Junan Li;
- Poi, Ming J.
Publication type:
Article
Daratumumab in multiple myeloma.
Published in:
2019
By:
- Nooka, Ajay K.;
- Kaufman, Jonathan L.;
- Hofmeister, Craig C.;
- Joseph, Nisha S.;
- Heffner, Thomas L.;
- Gupta, Vikas A.;
- Sullivan, Harold C.;
- Neish, Andrew S.;
- Dhodapkar, Madhav V.;
- Lonial, Sagar
Publication type:
journal article
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
Published in:
2019
By:
- Mina, Roberto;
- Joseph, Nisha S.;
- Kaufman, Jonathan L.;
- Gupta, Vikas A.;
- Heffner, Leonard T.;
- Hofmeister, Craig C.;
- Boise, Lawrence H.;
- Dhodapkar, Madhav V.;
- Gleason, Charise;
- Nooka, Ajay K.;
- Lonial, Sagar
Publication type:
journal article
Characterizing Pain Experiences: African American patients with multiple myeloma taking around-the-clock opioids.
Published in:
Clinical Journal of Oncology Nursing, 2020, v. 24, n. 5, p. 538, doi. 10.1188/20.CJON.538-546
By:
- Belcher, Sarah M.;
- Bruner, Deborah Watkins;
- Hofmeister, Craig C.;
- Kweon, Jaime;
- Meghani, Salimah H.;
- Yeager, Katherine A.
Publication type:
Article

Found: 32

Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas.

Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients.

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience.

Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma.

Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma.

The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo.

Characterization of multiple myeloma vesicles by label-free relative quantitation.

Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC.

Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant.

Population pharmacokinetics of lenalidomide in patients with B‐cell malignancies.

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.

Initial genome sequencing and analysis of multiple myeloma.

Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity.

Chemotherapeutic Agents Increase the Risk for Pulmonary Function Test Abnormalities in Patients With Multiple Myeloma.

Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies.

Evaluating the Impacts of CYP3A41B and CYP3A53 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant.

A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.

Pharmacokinetic‐Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High‐Dose Melphalan for Autologous Stem Cell Transplant.

Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.

Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.

Venetoclax ex vivo functional profiling predicts improved progression-free survival.

Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma.

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone.

Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.

XRCC1‐mediated DNA repair is associated with progression‐free survival of multiple myeloma patients after autologous stem cell transplant.

Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant.

Serum free light chains in myeloma patients with an intact M protein by immunofixation: potential roles for response assessment and prognosis during induction therapy with novel agents.

TTP disease course is independent of myeloma treatment and response.

CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation.

Daratumumab in multiple myeloma.

Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.

Characterizing Pain Experiences: African American patients with multiple myeloma taking around-the-clock opioids.